Dr. Hari L. Kumar
Chief Scientific Officer at cBio, a private disease diagnostics and tracking firm.
Expertise is in chromosome biology, functional genomics, and bioinformatics. Oversaw the development of the MRS and PATRN platforms.
At cBio, Dr. Hari led the team in engagements with the FDA, various universities and other US government organizations.
Former director of program management efforts the California Institute of Regenerative Medicine and the Myelin Repair Foundation.
PhD in Cell Biology from UC San Diego and a B.Sc. in Genetics from UC Davis